Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-04 4:08 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
10,885 | $3.43 | $37,336 | 430,931 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-24 4:20 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
11,702 | $4.24 | $49,616 | 731,816 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:20 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President & CEO |
16,644 | $4.45 | $74,066 | 308,518 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 4:10 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
12,115 | $9.86 | $119,454 | 322,839 (Direct) |
View |
| 2024-02-21 Sale |
2024-02-22 4:34 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
13,033 | $7.46 | $97,226 | 334,954 (Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 5:04 pm |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
7,437 | $7.83 | $58,232 | 214,618 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 7:05 pm |
BIOGEN INC. | BIIB | Sandrock Alfred Head of Research & Development |
7,672 | $440 | $3,375,680 | 10,169 (Direct) |
View |
| 2020-11-04 Sale |
2020-11-06 9:39 pm |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
1,500 | $350 | $525,000 | 13,066 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-21 Option Award |
2025-02-24 4:20 pm |
N/A 2035-02-21 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
435,000 | $0 | 731,816 (Direct) |
View |
| 2024-02-09 Option Award |
2024-02-16 4:59 pm |
N/A 2034-02-09 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
390,000 | $0 | 607,987 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-22 8:51 pm |
N/A 2033-02-17 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
360,000 | $0 | 462,055 (Direct) |
View |
| 2022-03-22 Option Award |
2022-03-23 6:35 pm |
N/A 2032-03-22 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred President and CEO |
1,040,600 | $0 | 1,040,600 (Direct) |
View |
| 2022-02-07 Option Award |
2022-02-09 4:27 pm |
N/A 2032-02-07 |
Voyager Therapeutics Inc. | VYGR | Sandrock Alfred Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 4:19 pm |
N/A 2024-02-18 |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
14,500 | $0 | 14,500 (Direct) |
View |
| 2021-02-12 Other |
2021-02-17 5:01 pm |
N/A 2021-02-12 |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
5,772 | $0 | 46,486 (Direct) |
View |
| 2021-02-12 Exercise |
2021-02-17 5:01 pm |
N/A 2021-02-12 |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
4,454 | $0 | 46,486 (Direct) |
View |
| 2021-02-12 Tax Withholding |
2021-02-17 5:01 pm |
N/A N/A |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
3,510 | $278.03 | 46,486 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-29 4:43 pm |
N/A N/A |
BIOGEN INC. | BIIB | Sandrock Alfred EVP, Research & Development |
3,728 | $0 | 16,794 (Direct) |
View |